Abstract
Following the Food and Drug Administration's release of recommendations on limiting the use of products containing hexachlorophene (HCP) for bathing newborn infants, 142 hospitals spontaneously reported outbreaks of neonatal staphybococcal disease. Epidemiologic investigations were carried out in 73 of these hospitals; 66 had confirmed outbreaks of neonatal staphylococcal disease. In 60 of the 66, discontinuation of HCP bathing of newborn infants preceded the epidemic. Alterations in handwashing policies did not appear implicated in any outbreak investigated. These findings suggested that discontinuation of HCP bathing of newborn infants was associated with increased incidence of neonatal staphylococcal disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
